Engaging Innovation | Friends of Cancer Research

Engaging Innovation

Featured Post

December 10, 2018

Friends of Cancer Research Annual Meeting 2018

This year’s Friends of Cancer Research (Friends) Annual Meeting started with a morning keynote by Anna Abram the Deputy Commissioner for Policy, Planning, Legislation and Analysis at the U.S. Food and Drug Administration (FDA). Abram discussed many different initiatives that have been led by Friends over the years including the...
More Posts

Recent Posts

No Results With Current Filter Choices

The FDA’s Budget: How Government Funds Safety and Efficacy

The U.S. Food and Drug Administration (FDA) fulfills its mission to protect and advance the public health by overseeing the development and approval of new medical products and ensuring that they are safe and effective for American consumers. When taking into consideration the full range of products the FDA oversees,...

A Plea to Make Cancer Clinical Trials More Patient Friendly

Jim Omel is a myeloma patient and a cancer research advocate. He spoke at the 2017 Friends of Cancer Research Annual Meeting and was an author of the panel 2 whitepaper, Data Generation to Support Cross-Labeling of Indications for Combination Products. Below are his abridged remarks from the meeting. To...

Friends of Cancer Research Annual Meeting 2017

Panel 1 Whitepaper - Panel 1 Slides Panel 2 Whitepaper - Panel 2 Slides Panel 3 Whitepaper - Panel 3 Slides   This year’s Friends Annual Meeting took place on November 15, 2017. The event began with a keynote by FDA Commissioner Dr. Scott Gottlieb. During his remarks, Dr. Gottlieb reiterated previous commitments for...

The Magic of Summer at Camp Fantastic

With summer now behind us, we thought it would be a good time to reflect on one of the special experiences our science policy analyst, Diana Merino, had over the summer...   This summer, for the second year in a row, I got to spend a week volunteering at Camp Fantastic, a...

Keeping Patients at the Forefront of Our Work

I was 18 when my life was turned upside down by cancer. My mother was diagnosed with a highly aggressive malignancy after a colonoscopy due to a flair-up of Crohn’s disease. She spent the next two months in the hospital after the surgery to remove the malignancy left her near...

Data Driven: Mining ClinicalTrials.gov – Institutions, Funding, and Areas of Focus

We thought it would be interesting to explore data from agencies whose work most closely impacts biomedical innovation, namely the National Institutes of Health (NIH), the Food and Drug Administration (FDA), and the Centers for Medicare and Medicaid Services (CMS). In the first of a series, Friends investigated the NIH-sponsored site ClinicalTrials.gov. 

21st Century Cures is Moving Quickly Through the Legislative Process - Here's What You Should Know

Here's what you should know on 21st Century Cures and how quickly it is moving through the legislative process.

first
prev
1
2
next
last
Back to Top